SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotransplant(BTRN)
BTRN 35.340.0%Nov 6 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Arthur Radley who wrote (994)8/14/2001 1:04:00 PM
From: scaram(o)uche  Read Replies (2) of 1475
 
A well-organized group of hedgies/shorts has been attacking small cap biotechs when market caps aren't backed with a large cash stash. Any developmental stage company with a price:book above 4 seems to be vulnerable.

The short interest for BTRN is up 4.9X in the last three reports, and it will be interesting to see the August numbers. If 507 is hot, they'll lose their stash, homes, and all worldly goods -- including their other shorts.

Kudos to Lebowitz et al. I like the Gambro deal. I still am not happy with having acquired Eligix, but..... not bad IMO!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext